Detalles de la búsqueda
1.
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.
Oncologist
; 28(8): 682-690, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946994
2.
Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions.
Breast Cancer Res Treat
; 196(1): 215-220, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36087190
3.
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?
Support Care Cancer
; 30(3): 1903-1906, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741653
4.
Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study.
BMC Med Imaging
; 22(1): 182, 2022 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266631
5.
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
Oncologist
; 26(2): 101-106, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33230905
6.
Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
BMC Cancer
; 21(1): 1150, 2021 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706686
7.
CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice.
Eur J Haematol
; 106(5): 634-642, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33527479
8.
Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive Resistance.
Adv Exp Med Biol
; 1188: 251-266, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820393
9.
Implementing a comprehensive translational oncology platform: from molecular testing to actionability.
J Transl Med
; 16(1): 358, 2018 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30551737
10.
BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.
Oncologist
; 20(6): 593-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25948675
11.
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.
Invest New Drugs
; 33(4): 890-4, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25947565
12.
Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor.
Nutrients
; 15(21)2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37960281
13.
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Nat Commun
; 14(1): 4444, 2023 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37488191
14.
A randomized-controlled trial comparing supervised aerobic training to resistance training followed by unsupervised exercise on physical functioning in older breast cancer survivors.
J Geriatr Oncol
; 13(2): 152-160, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426142
15.
Impact of TP53 mutations in Triple Negative Breast Cancer.
NPJ Precis Oncol
; 6(1): 64, 2022 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36085319
16.
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.
Cell Rep Med
; 3(2): 100525, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243422
17.
Study protocol for the Exercising Together© trial: a randomized, controlled trial of partnered exercise for couples coping with cancer.
Trials
; 22(1): 579, 2021 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34461975
18.
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.
NPJ Precis Oncol
; 5(1): 28, 2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772089
19.
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.
NPJ Precis Oncol
; 5(1): 92, 2021 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34667258
20.
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors.
Sci Rep
; 11(1): 13630, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34211050